COVID-19

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease |
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs |
Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment – A Randomized Clinical Trial | Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach | Timing and Predictors of Loss of Infectivity Among Healthcare Workers with Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study |
Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study

Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial |
Prevalence of Orthostatic Intolerance in Long COVID Clinic Patients and Healthy Volunteers: A Multicenter Study | Autonomic Cardiac Function in Children and Adolescents with Long COVID: A Case-controlled Study | Iron Dysregulation and Inflammatory Stress Erythropoiesis Associates with Long-term Outcome of COVID-19

Vaccine Effectiveness Against Long COVID in Children | Impact of Vaccination on the Association of COVID-19 with Cardiovascular Diseases: An OpenSAFELY Cohort Study | The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults |
Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform |
Cognition and Memory after COVID-19 in a Large Community Sample |
Prospective Memory Assessment Before and After Covid-19 |
What is the Impact of Long-term COVID-19 on Workers

Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals |
Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition

Self-administered versus Clinician-performed BinaxNOW COVID Rapid Test: A Comparison of Accuracy |
The Impact of COVID-19 Vaccination Prior to SARS-CoV-2 Infection on Prevalence of Long COVID among a Population-based Probability Sample of Michiganders, 2020-2022 |
Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection |
Long-term risks of Respiratory Diseases in Patients Infected with SARS-CoV-2

Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission |
Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination |
Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease |
Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease

Estimating the Heritability of SARS-CoV-2 Susceptibility and COVID-19 Severity | Neonatal Outcomes After COVID-19 Vaccination in Pregnancy | Contralateral Second Dose Improves Antibody Responses to a Two-dose mRNA Vaccination
Regimen | Substantial Health and Economic Burden of COVID-19 During the Year After Acute Illness
Among US Adults Not at High Risk of Severe COVID-19

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons | Effectiveness of High-dose vs. Standard-dose Quadrivalent Influenza Vaccine against Recurrent Hospitalizations and Mortality in Relation to Influenza Circulation: A Post-hoc Analysis of the DANFLU-1 Randomized Clinical Trial